General · 30 June 2026
GLP-1 drugs linked to reduced smell and taste
Long-term users of GLP-1 drugs for type 2 diabetes face an increased risk of problems with their sense of smell and taste. A new analysis found these patients had an 81% higher rate of smell disturbances and 52% higher rate of taste issues than those on other diabetes meds. Researchers are calling for closer monitoring, though some doctors say the benefits outweigh this potential side effect.
Reported by Benefits and Pensions Monitor · How we write briefs